Lymphoblastoid interferon in chronic hepatitis C patients who were "non responders" to recombinant interferon alpha

Related Experiment Video

Updated: Oct 17, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

G Budillon1, L Cimino, B D'Ascoli

  • 1Cattedra di Gastroenterologia, Second School of Medicine, Università di Napoli Federico II, Italy.

Archives of Virology. Supplementum
|January 1, 1993
PubMed

Insights

Hepatitis C patients non-responsive to recombinant alpha interferon showed improved alanine transaminase (ALT) levels after switching to lymphoblastoid interferon. This suggests potential variable virus or host response to different interferon types.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic hepatitis C virus infection is a significant global health concern.
  • Recombinant alpha interferon is a standard treatment, but some patients exhibit non-responsiveness.
  • Investigating alternative interferon therapies is crucial for improving treatment outcomes.

Purpose of the Study:

  • To evaluate the efficacy of lymphoblastoid interferon in chronic hepatitis C patients who previously failed recombinant alpha interferon therapy.
  • To explore the potential for variable responsiveness of the hepatitis C virus and/or host to different interferon types.

Main Methods:

  • A cohort of 21 chronic hepatitis C patients, non-responsive to recombinant alpha interferon, received lymphoblastoid interferon after a four-month washout period.
  • Alanine transaminase (ALT) serum levels were monitored during and after treatment.

Main Results:

  • At the end of lymphoblastoid interferon treatment, 9 out of 21 patients (43%) achieved normal ALT serum levels.
  • During a 12-month follow-up period without treatment, 3 patients maintained normal ALT levels, while 4 relapsed.
  • No prior reports exist comparing the therapeutic efficacy of these two specific interferon types.

Conclusions:

  • Lymphoblastoid interferon demonstrates potential efficacy in a subset of chronic hepatitis C patients resistant to recombinant alpha interferon.
  • The observed response may be attributed to immune modulation from the treatment interval or differential hepatitis C virus sensitivity.
  • Further research is warranted to elucidate the mechanisms behind variable interferon responsiveness in hepatitis C.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...